ViaNautis

ViaNautis is a nanomedicine company developing a polymer nanoparticle platform for the targeted intracellular delivery of genetic therapeutic payloads across difficult-to-penetrate biological barriers.

The platform is designed to encapsulate a broad range of genetic cargoes and guide them to specific tissues and cell types, with current programmes focused on central nervous system rare diseases and cystic fibrosis.

The company builds an internal pipeline and licenses its technology to pharmaceutical and biotechnology partners.